Arterial Filter Market Share to Witness Significant Revenue Growth

Arterial Filter Market Summary

The global arterial filter market size was estimated at USD 616.4 million in 2024 and is projected to reach USD 870.7 million by 2030, growing at a CAGR of 6.0% from 2025 to 2030. This consistent growth reflects the increasing clinical importance of arterial filters in cardiac and cardiovascular procedures. The market expansion is primarily driven by the rising incidence of cardiovascular diseases worldwide, which has significantly increased the demand for cardiac surgeries and interventional procedures. In addition, continuous advancements in cardiopulmonary bypass technologies have improved surgical outcomes and patient safety, further supporting the adoption of arterial filters in clinical settings.

Furthermore, the growing geriatric population, which is more vulnerable to heart related conditions, along with improved access to healthcare services in emerging economies, is fueling the demand for safer and more efficient surgical interventions. These factors are directly contributing to the expansion of the arterial filter industry. One of the major drivers of the market is the increasing global burden of cardiovascular diseases. For example, in October 2024, the European Journal of Preventive Cardiology reported that cardiovascular diseases remain the leading cause of death and illness globally. Modifiable lifestyle factors such as unhealthy diets, physical inactivity, smoking, and aging are the primary contributors. Since 1990, the number of individuals affected by heart disease has nearly doubled, resulting in a substantial rise in healthcare burden and medical expenditures. In 2019 alone, more than 500 million people were living with heart disease, with Europe and the United States spending over 280 billion euros and USD 400 billion, respectively, on its management.

Key Market Trends & Insights

• North America held the largest share of the global arterial filter market, accounting for 40.52% of the industry. This dominance can be attributed to advanced healthcare infrastructure, high prevalence of cardiovascular diseases, early adoption of innovative surgical technologies, and strong presence of key medical device manufacturers in the region.
• The arterial filter market in the Asia Pacific region is expected to grow at the fastest CAGR of 6.7% during the forecast period. Rapid improvements in healthcare infrastructure, rising awareness of cardiac health, increasing healthcare expenditure, and a growing patient population are key factors driving growth in this region.
• Based on end use, the hospitals segment dominated the market with a 40.95% share. Hospitals remain the primary setting for complex cardiac surgeries and cardiopulmonary bypass procedures, which drives high demand for arterial filters.
• In terms of age category, the adult segment led the market with a 78.61% share in 2024. The higher prevalence of cardiovascular diseases among adults compared to pediatric populations largely explains this dominance.

Order a free sample PDF of the Arterial Filter Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 616.4 Million
• 2030 Projected Market Size: USD 870.7 Million
• CAGR (2025-2030): 6.0%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Some of the leading companies in the arterial filter industry are Medtronic, Pall Corporation, Fresenius Medical Care AG, and Terumo Corporation. These companies prioritize new product development, Research & Development (R&D) investments, and strategic M&As to strengthen their market positions.

Key Players

• Medtronic
• Pall Corporation
• Fresenius Medical Care AG
• Terumo Corporation
• NIPRO
• Haemonetics Corporation
• ICU Medical, Inc.
• Braile Biomédica
• LivaNova, Inc.
• EUROSETS

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The arterial filter market is steadily expanding due to the rising global prevalence of cardiovascular diseases and increasing demand for cardiac surgical procedures. Advancements in cardiopulmonary bypass technologies and improved healthcare access are further supporting market growth. North America continues to lead the market, while Asia Pacific shows strong growth potential. The dominance of hospitals and adult patient segments highlights the clinical focus of arterial filter usage. Overall, continued technological innovation and growing awareness of cardiac health are expected to sustain market expansion in the coming years.